B-Cell Prolymphocytic Leukemia (B-PLL)

Alias:
B-Pll
Prolymphocytic Leukaemia of B-Cell Type Without Mention of Remission
Prolymphocytic Leukemia, B-Cell Type
Leukemia, Prolymphocytic, B-Cell
Pll- [prolymphocytic Leukaemia]
B Cell Prolymphocytic Leukemia
Prolymphocytic Leukaemia
Favorite
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
B-Cell Prolymphocytic Leukemia, also known as b-pll, is related to prolymphocytic leukemia and lymphoproliferative syndrome. An important gene associated with B-Cell Prolymphocytic Leukemia is CD5 (CD5 Molecule), and among its related pathways/superpathways are Innate Immune System and PI3K-Akt signaling pathway. The drugs Ofatumumab and Obinutuzumab have been mentioned in the context of this disorder. Affiliated tissues include bone marrow and spleen, and related phenotypes are cellular and normal
Related ID:
ICD11:1997215876

Basic Information

Inheritance
Age of Onset
Prevalence
Related Gene
Related Mouse Models
Reference
MALACARDS
--
Adult
<1/1000000
12
131
--

Medical Symptom

#
Categorization
Description
HPO Frequency
Orphanet Frequency
HPO Source Accession
No data available

Gene & Mutation

#
Gene
Function
Score
Mutations
No data available

Related Drugs

Name
CAS Number
Status
Phase
No data available

Disease Model

Category
Name
MGI
Related Gene
Strain of Origin
Publications
No data available

References Literature

Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Comparison
Al agent
Tutorials
Back to top